JAKARTA (Indotelko) – More than 320 million people worldwide suffer from chronic obstructive pulmonary disease (COPD), a condition that causes severe chest and breathing problems. As the coronavirus pandemic rapidly escalates, the COPD Foundation, a non-profit organization aimed at accelerating innovation in disease treatments to be more effective and affordable, collaborates with global analytics firm SAS to use its data to measure the impact on this vulnerable population and develop an urgent and urgent program. through natural language processing and machine learning of survey data collected by the COPD community. “By using SAS to sift through volumes of text data and analyze sentiment, we can quickly concentrate on topics relevant to our community and provide answers and support in real time,” said COPD President and Chief Scientific Officer Ruth Tal-Singer. At the start of the pandemic, forging partnerships across governments, healthcare and companies, the COPD Foundation launched a series of global surveys of its more than 47,000 members. Their aim is to gather a hands-on perspective from the COPD community about their concerns and general needs as well as the specific cases of Covid 19 (tests and diagnosis, symptoms, hospitalizations, drugs, and more). To date, the organization has received a lot of in-depth information from its members through three surveys that have been carried out specifically for Covid 19. The unstructured nature of the data from the various survey participants’ responses made it difficult for researchers to analyze and extrapolate their findings. “You can collect data all day long, seven days a week, but you can’t really benefit much from it unless you can analyze it properly. We need to partner with other parties who are more expert in helping us collect and analyze all incoming data. We can understand and respond to data, “explained the Head of Information from the COPD Foundation Vincent Malanga. Leveraging SAS Viya technology in visual analysis and text sentiment analysis enables organizations to rapidly explore unstructured data volumes, identify patterns and trends, and generate reports. In addition, the COPD Foundation can innovate faster to virtually help patients who are at higher risk of developing severe disease due to Covid 19, help improve and maintain patient access to health care, provide emotional well-being support, and address concerns about drug supply. In addition, this analytical technology can also capture other things that are of particular concern to organizations such as access to oxygen, impact on work, and pulmonary rehabilitation that have developed during the pandemic.
<!–
– –>
Fundamental measures of the impact of Covid are still continuing, with ongoing data analysis helping staff direct the resources that have proven to be most beneficial to COPD patients, their families and the medical workers who care for them. “The more we can do with analytics, the better we can serve all our patient and nursing partners. We can allocate resources more effectively through successful integration of information from multiple sources, ”said Tal-Singer.
<!–
– –>
“SAS has world-class analytics technology, and can meet the needs of our enterprise architectural approach, which is scalable, secure, flexible and extensible. We want this software to adapt to what we need to do in the future, such as the possibility of integrating with open source solutions and a pre-trained language model. And SAS gave us the freedom to do that, “said Malanga. (Wn)
– .